资讯
14 小时on MSN
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果